Finzati - Logo
COLL logo

Collegium Pharmaceutical, Inc.

COLL • Drug Manufacturers - Specialty & Generic
$23.53
▼ -0.17 (-0.72%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.
Market Cap
$763.80M
Growth
—
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 8.1%Positive revenue growth · 32.8%Positive free cash flow · 10.33Consistent free cash flow · 5/5Healthy liquidity · 1.57
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:11 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$23.53
Change-0.72%
Shares Out32.46M
Market Cap$763.80M
Enterprise Value$1.73B
52W Range28.93 - 50.79
Beta0.73
P/E15.94
P/S0.95
P/B2.45
P/FCF1.98
EV/Sales2.14

Investment DNA

How strong this company looks for long-term investors

78
out of 100
Business Quality
Margins, moat, returns
63/100
Financial Strength
Debt, cash, stability
54/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
79/100
Why this score▼
Stable or improving margins · 8.1%Positive revenue growth · 32.8%Positive free cash flow · 10.33Consistent free cash flow · 5/5Healthy liquidity · 1.57High debt level · 3.12

Analyst view

Analyst sentiment and price target

COLL
Analyst sentiment
Based on 12 analyst votes · 2026-09-04
79/100
Bullish
Bullish
8
Hold
3
Bearish
1
Price Target
2026-08-07
Low
$58.00
Mean
$58.00
Median
$58.00
High
$58.00

Company Overview

IPO: 5/7/2015
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 2.45
Debt / Equity i: 3.12
Operating Margin: 23.97%
Net Margin: 8.05%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: 3.12
Current Ratio: 1.57
Quick Ratio: 1.48
Status: Moderate

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

SANTINI GINO
Transaction: 06/08/2026
SELL
Change
-8,700
Price
$16.49
Filing
06/10/2026
Type
SELL
SANTINI GINO
Transaction: 06/08/2026
BUY
Change
+8,700
Price
$16.49
Filing
06/10/2026
Type
BUY
Freund John Gordon
Transaction: 05/18/2026
SELL
Change
-20
Price
$34.05
Filing
05/20/2026
Type
SELL